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Lamellar ichthyosis is a severe, generalized, auto-
somal recessive genodermatosis characterized clinically
by large, parchment-like scales and histologically by
acanthosis and marked hyperkeratosis. Genetic hetero-
geneity in lamellar ichthyosis has been recognized with
reports of two linked loci (on chromosomes 14q11 and
2q33–35). In a cohort of four small families with lamellar
ichthyosis we found confirmatory evidence for linkage
(p ø 0.01) to D14S275, a microsatellite marker close
to transglutaminase 1 on chromosome 14q11. We also
identified two novel transglutaminase 1 mutations in an
affected sibling pair from one of these families. The
paternal mutation in exon 3, 1387insCAGC, causes a
frameshift predicted to result in premature termination
of translation within the same exon. The maternal muta-
Lamellar ichthyosis (LI, MIM 242100) is a clinicallyheterogeneous congenital disorder of keratinization (Phil-lips and Baden, 1993). The disease has an autosomalrecessive mode of inheritance and an estimated incidenceof 1:250,000. Affected individuals are usually erythrod-
ermic and encased in a collodion membrane at birth and go on to
develop large, parchment-like, brown scales covering the entire
body with flexural predominance. Although nonspecific, the most
prominent histologic findings in LI are acanthosis and hyperkeratosis.
Two separate studies have mapped the disease gene for autosomal
recessive LI to chromosome 14q near the transglutaminase 1 locus
(TGM1) in some of the families studied (Russell et al, 1994;
Huber et al, 1995). Individuals affected at this locus display a marked
reduction in keratinocyte transglutaminase (TGK or transglutaminase
1) activity, and several laboratories have identified deleterious
mutations in the TGM1 gene (Huber et al, 1995; Parmentier et al,
1995; Russell et al, 1995). Recently, the identification of a second
disease locus on chromosome 2q33–35 has confirmed the long-
suspected presence of genetic heterogeneity in LI (Parmentier et al,
1996). The existence of additional kindreds apparently unlinked to
both TGM1 and 2q suggests that mutations in at least one additional
gene can cause this genodermatosis (Bale et al, 1996; Parmentier
et al, 1996).
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tion in exon 8, 4561delAC, also causes a frameshift and
a premature stop codon in this exon. The mother of
these siblings recently became pregnant with twins. Geno-
typing and direct sequencing of DNA isolated from fetal
amniotic fluid cultures revealed the presence of the
paternal but the absence of the maternal mutation, thus
predicting a normal skin phenotype. Both twins were
born with normal-appearing skin. Our findings demon-
strate that mutations of both alleles of the transglutamin-
ase 1 gene are the cause of lamellar ichthyosis in this
family, and illustrate an emerging clinical application of
molecular genetics in dermatology. Key words: genoder-
matoses/human genetics/linkage analysis/prenatal dia-
gnosis. J Invest Dermatol 110:179–182, 1998
We investigated genetic linkage of LI to TGM1 in four families
with two or more affected siblings. A confirmatory lod score
(p ø 0.01) was found for D14S275, a microsatellite marker close
to TGM1. We also identified two novel TGM1 mutations in one
of these families and report the use of these findings to provide
prenatal testing of LI in a recent twin pregnancy.
MATERIALS AND METHODS
Clinical evaluation and sample collection Study subjects were identified
from the billing records of the University of Michigan Dermatology clinic.
All pedigrees were Caucasian and nonconsanguineous. After receiving
informed consent under a protocol approved by the Institutional Review
Board, subjects were examined by a dermatologist and a blood sample
(30 ml) was obtained. The diagnosis of LI was established through total
body skin examination using standard criteria (Phillips and Baden, 1993).
Ten milliliters of blood was used for establishment of lymphoblastoid cell
lines and the remainder was used to isolate genomic DNA as previously
described (Nair et al, 1995). Most experiments were performed using
lymphoblastoid cell line DNA.
Genotyping and linkage analysis Four LI kindreds were genotyped for
four polymorphic microsatellite markers on chromosome 14q11. The
map order was cen–MYH7–(5.1 cM)–TGM1–(0 cM)–D14S264–(4.2 cM)–
D14S275–q ter (Gyapay et al, 1994; Russell et al, 1994). The TGM1
microsatellite marker is located in intron 14 of the TGM1 gene. Genotyping
methods have been described in detail elsewhere (Nair et al, 1995). Allele
sizes were ascertained by comparison with sizes obtained for CEPH individual
no. 134702, a known standard (Gyapay et al, 1994). Linkage analysis of the
genotype data was performed using LINKAGE 5.1 (Ott, 1991) under an
autosomal recessive model, assuming full penetrance and a disease allele
frequency of 0.002, calculated according to Hardy–Weinberg equilibrium
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Table I. Linkage analysis of 14q11 loci in four lamellar
ichthyosis kindreds
Recombination fraction (θ)
Marker 0 0.1 0.2 0.3 0.4
MYH7 22.1526 0.2547 0.3942 0.2523 0.0792
TGM1 20.4173 0.2123 0.1572 0.0720 0.0162
D14S264 20.2634 0.3681 0.2924 0.1670 0.0610
D14S275 0.8565 1.1544 0.7452 0.3447 0.0794
using the mendelian inheritance in man value for the prevalence of LI
(1/250,000).
DNA fragment amplification The complete TGM1 gene contains 15
exons, ranging from 89 to 403 bp, interspersed by 14 introns of highly
variable size (Kim et al, 1992). DNA fragments containing most TGM1
exons were amplified by polymerase chain reaction (PCR) using the primers
described by Russell et al (1995). The fragment containing exons 5–6 was
amplified using primers 59-GGCTGGGGGTTCTTAGGAATCC-39 and
59-GGTGAGGCCCAGGGAGAGAAC-39, exon 12 using primers 59-GGAA-
TTGGAACCTCACCCTTGAC-39 and 59-TCCATGTCCACAGCCCTG-
AG-39, and exon 13 using primers 59-TAAGTGCTCCTTACCCAG-
CCCTGCC-39 and 59-CGCCCACCTCTGATGTCCTTATC-39. PCR was
performed in a volume of 50 µl containing 200 ng of lymphoblastoid cell
line DNA, 0.5 mM of each primer, 200 mM each of dATP, dCTP, dGTP,
and dTTP, 50 mM KCl, 10 mM Tris-HCl pH 9.0, 1.5 mM MgCl2, 5%
dimethyl sulfoxide, 0.5% Triton X-100, and 1 U Taq polymerase (Promega,
Madison, WI). The PCR reaction was run with an initial denaturation at
94°C for 3 min, followed by 30 cycles of 1 min at 94°C, 1 min at 55°C,
and 1 min at 72°C, and a 7 min extension at 72°C on an MJ Research
PTC-100 thermal cycler (Watertown, MA). PCR products were run on
1.5% agarose gels and DNA was purified for sequencing by electro-elution.
Mutation detection Approximately 0.5 pmol PCR product was sequenced
using the SequenaseTM PCR Product Sequencing Kit (Amersham Life
Sciences, Arlington Heights, IL) with [35S]-dATP label. PCR amplification
primers were used as sequencing primers, except for the anti-sense primer
59-TTCAGCACAGATGGGCAGT-39 used for sequencing of exon 9.
Mutations identified by direct sequencing of the PCR products were
confirmed by sequencing of cloned PCR products. Several clones of each
cloned PCR product, generated using the pCRIITM vector (Invitrogen, San
Diego, CA) were sequenced on an ABI DNA sequencer (Applied Biosystems,
Foster City, CA, model 373 A).
Prenatal testing Following genetic counselling and obtaining informed
consent with the approval of the Institutional Review Board of the
University of Michigan, amniotic fluid was obtained in the fourteenth week
of pregnancy from each amniotic cavity of the twin pregnancy (amniocentesis
was indicated due to advanced maternal age and a history of Down’s
Syndrome in a previous pregnancy). Genomic DNA was isolated from
µ2 3 106 fetal cells cultured from the amniotic fluid. Genotyping was
performed using microsatellite markers MYH7 and TGM1, and direct
sequencing of exons 3 and 8 was performed as described above.
RESULTS
Genotyping and linkage analysis Using the criteria recently
recommended for genome-wide linkage analysis (Lander and
Kruglyak, 1995), marker D14S275 provided confirmatory evidence
for linkage of LI to the TGM1 region (p ø 0.01), even in this
relatively small sample of four kindreds (Table I). Genotype data
are only shown for family 2 in which further mutation analysis was
pursued (Fig 1).
Sequence analysis of TGM1 exons in family 2 Direct
sequencing of the 764 bp PCR fragment containing exons 2 and
3 revealed a heterozygous CAGC insertion in exon 3 after position
1387 [sequence numbering according to Kim et al (1992)] in affected
individuals 2–1 and 2–2, and the unaffected father 2–3 (Fig 2).
The insertion was not found in the unaffected mother 2–4. The
cloned PCR fragment from individual 2–1 was sequenced, and
clearly carried the observed insertion (data not shown).
Direct sequencing of the 498 bp PCR fragment containing exons
Figure 1. Genotype data of microsatellite markers MYH7, TGM1,
D14S264, and D14S275 for family 2. u, males; s, females; solid symbols
denote affected individuals, open symbols denote unaffected individuals. Marker
allele sizes are arrayed vertically as the most likely haplotypes based on the
available parental data.
Figure 2. TGM1 exon 3 contains a 4 bp insertion in the paternal
chromosome shared by affected siblings of LI family 2. The
autoradiograph shown demonstrates a CAGC insertion after position 1387
(1387insCAGC) in the mutant allele present in the affected siblings (2–1 and
2–2) and father (2–3) of family 2, and not in the wild-type control.
Figure 3. TGM1 exon 8 contains a 2 bp deletion in the maternal
chromosome shared by affected siblings of LI family 2. The autoradiograph
shown demonstrates a CA deletion at position 4561–4562 (4561delAC) in the
mutant allele present in the affected siblings (2–1 and 2–2) and mother (2–4)
of family 2, and not in the wild-type control
8 and 9 revealed a heterozygous AC deletion in exon 8 at position
4561–62 [sequence numbering according to Kim et al (1992)] in
affected individuals 2–1 and 2–2. The identical mutation was found
in the unaffected mother 2–4 and maternal grandfather 2–5, but
not in the unaffected father (Fig 3). The deletion was also confirmed
by sequencing of the cloned PCR fragment (data not shown).
None of the previously reported TGM1 mutations (Huber et al,
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Figure 4. Prenatal testing reveals that only the paternal LI allele is
transmitted to unborn twins in family 2. Except for the maternal
grandparents (2–5 and 2–7), all family members were typed for microsatellite
markers MYH7 (A) and TGM1 (B). Allele sizes are indicated to the left of the
autoradiographs. The maternal TGM1 alleles are 190 and 192 bp long (individual
2–4), whereas the paternal alleles are 188 and 190 bp long (individual 2–3).
There is comigration between the 188 bp allele and an artifactual ‘‘shadow
band’’ generated from the 190 bp allele by Taq polymerase. The fact that the
190 bp bands obtained for individuals 2–7 and 2–8 are much darker than the
188 bp bands indicates homozygosity for the 190 bp allele. (C) Pedigree
diagram, showing transmission of disease haplotypes. MYH7 and TGM1 allele
sizes are separated by vertical bars only when the haplotype could be determined
with certainty. Striped halves of symbols represent the paternally inherited exon
3 mutation (1387insCAGC); solid halves represent the maternally inherited
exon 8 mutation (4561delAC). The fetuses (of unknown sex and zygosity at
the time of analysis) are represented by diamonds.
1995; Parmentier et al, 1995; Russell et al, 1995) were detected in
these individuals.
Prenatal testing Recently, individual 2–4 (Fig 1) became
pregnant with twins. Amniocentesis was indicated for assessment of
the genetic risk to the fetuses due to advanced maternal age and a
history of Down’s Syndrome in a previous pregnancy. The family
expressed interest in prenatal testing for LI as well. DNA derived
from fetal amniotic fluid cultures was genotyped for the MYH7
and TGM1 loci (Fig 4A,B). DNA from other family members
previously studied was re-genotyped in parallel. As shown in
Fig 4(C), the disease-associated paternal haplotype (MYH7 136/
TGM 1190) is inherited by both fetuses; however, the normal
maternal haplotype (MYH7 140/TGM1 190) is also inherited by
both unborn twins. This finding was confirmed by sequencing
DNA from amniotic fluid cells after PCR amplification of exons 3
and 8. As expected, sequencing revealed the presence of the paternal
1387insCAGC mutation in exon 3, and the absence of the maternal
4561delAC mutation in exon 8 in both fetuses (data not shown).
We therefore predicted both twins to be phenotypically normal
carriers of the paternal TGM1 mutation. Six months later both
twins were born in good health with completely normal skin.
DISCUSSION
Transglutaminases catalyze the post-translational modifications of
proteins by transamidation of available glutamine residues in a Ca21-
dependent manner (Greenberg et al, 1991). Five related but distinct
transglutaminases have been identified: keratinocyte transglutaminase
(TGK or transglutaminase 1), tissue transglutaminase (TGC or
transglutaminase 2), epidermal transglutaminase (TGE or transglutami-
nase 3), human blood coagulation factor XIII, and erythrocyte band
4.2. Transglutaminase 1 plays a key role in the formation of the
cornified envelope, a highly insoluble structure that replaces the
plasma membrane during terminal differentiation of keratinocytes.
The enzyme cross-links cornified envelope precursors, such as
involucrin and loricrin, by catalyzing the formation of isodipeptide
Nε-(γ-glutamyl)lysine bonds, leading to the formation of a scaffold
onto which other reinforcement proteins are attached (Hohl et al,
1991; Kim et al, 1992). The mechanism by which TGM1 function
is impaired by the novel mutations presented here is not known;
however, the frameshifts caused by the CAGC insertion in exon 3
and the AC deletion in exon 8 both lead to premature stop codons
that would be predicted to create premature translation termination.
The former would eliminate the active site and calcium-binding
site of transglutaminase 1, whereas the latter mutation would
eliminate only the calcium-binding site (Greenberg et al, 1991).
Alternatively, by analogy to frameshift mutations in Herlitz junctional
epidermolysis bullosa (Baudoin et al, 1994) and numerous other
genetic disorders (McIntosh et al, 1993), these mutations may result
in mRNA instability, which would effectively generate null alleles.
Consistent with this possibility, the only frameshift mutation
previously reported in LI was shown to strongly reduce the level
of normal transcripts (Huber et al, 1995). Quantitation of mutant
transcript levels from a skin biopsy or keratinocytes cultured from
these patients will be required to address this issue.
Previous reports of prenatal diagnosis of LI were based on
morphologic examination of amniotic fluid cells and fetal skin
biopsies at a gestational age of 17–21 wk (Perry et al, 1987; Akiyama
et al, 1994). In other genodermatoses such as epidermolytic
hyperkeratosis and recessive dystrophic epidermolysis bullosa, several
laboratories have used PCR-based assays with DNA obtained by
chorionic villus sampling or amniocentesis to perform prenatal
diagnosis at 10–15 and 12–15 wk, respectively (Rothnagel et al,
1994; Christiano et al, 1996). This noninvasive approach and early
diagnosis of diseases with such significant morbidity and life-
threatening complications are clearly important advancements in
modern-day medicine. In this paper we present for the first time
a DNA-based prenatal testing of LI at a gestational age of 14 wk.
Here we demonstrate that in individual cases the detection of
mutations in TGM1 (or other genes yet to be recognized) can
have significant clinical applications in families affected with LI.
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